Areas and lines of research

The R+D+i work carried out by BioKeralty is carried out thanks to its participation in projects at a national and international level in collaboration with various strategic partners and entities. Our research work encompasses a wide variety of areas within which different lines of research and projects can be identified.

Genomics and personalized medicine

Genomics (also known as personalized medicine) seeks to identify genetic, environmental and lifestyle factors to prevent, diagnose or treat a disease. Genomics has been also defined as “precision medicine".

Nowadays, this new discipline is being implemented in the traditional health system being the increase in patient’s awareness, the expansion of infrastructures and the improvement of information management some examples. The permanent collaboration with clinics and institutes (both public and private) is essential for the establishment of national and international alliances to normalize personalized medicine practice in the clinical setting.

Today, the main interest areas are, on the one hand, the development of genetic tests for neurodegenerative, metabolic, orphan and oncological diseases and, on the other hand, the development of personalized medical devices for their application in regenerative medicine. As well, it is also remarkable the work done on the implementation of a genomic sequencing platform able to analyze, interpret and associate genetic variables in certain diseases.

Research areas and projects:

Line 1 – Predictive medicine

It is focused on the development of genetic tests for neurodegenerative, metabolic, orphan and oncological diseases.

Line 2 – Personalized medicine

This specialty is oriented to the development of personalized medical devices for application in other medicine specialties such as regenerative medicine.

Line 3 – Genomic sequencing

Genomic sequencing seeks the development of a genomic sequencing platform that includes primary, secondary and tertiary analysis, not only of exomes but also of the entire genome to associate new genetic variables with the main diseases under study, such as, neurological disorders. congenital malformations, hematological problems (bleeding disorders) and cancer.